{"database": "lobbying", "table": "lobbying_activities", "rows": [[2638986, "8f59bb4d-36cf-4daa-9fee-52c321e56a60", "Q2", "PUBLIC CITIZEN", 32362, "PUBLIC CITIZEN", 2021, "second_quarter", "PHA", "Covid-19 Vaccine Manufacturing and access and related funding, drug price negotiation, FAIR drug pricing Act, clinical trial cost transparency, HR 3 Lower drug prices now act, HR 2096-SACKLER Act, Affordable medications act, prescription drug price spike remedies, Medical Innovation act, National Biomedical research act, USTR access to medicines position, HR 3778/S 1976 (NOVID act), Aducanumab, S.1435-Affordable Prescriptions for Patients act,", "Consumer Product Safety Commission (CPSC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,Occupational Safety & Health Administration (OSHA),Securities & Exchange Commission (SEC),SENATE,Treasury, Dept of,White House Office", null, 150000, 0, 0, "2021-07-16T08:31:35.043000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2638986"], "units": {}, "query_ms": 10.026384028606117, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}